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A B S T R A C T
Isothermal titration calorimetry (ITC) along with attenuated total relectance Fourier transform infrared spec-
troscopy (ATR-FTIR), scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM/EDX) and
high-performance liquid chromatography (HPLC) were employed to investigate the process of adsorption of
propranolol hydrochloride (PPN) onto magnesium aluminium silicate (MAS) and to characterise the MAS-PPN
particles formed upon complexation. The composition of MAS was conirmed by infrared (IR) spectroscopy and a
calcimeter. The calorimetric results conirmed the binding between PPN and MAS at various pHs and tem-
peratures. The overall change in enthalpy was found to be exothermic with a comparatively small entropic
contribution to the total change in Gibbs free energy. These indings suggest that the binding process was
enthalpically driven and entropically unfavourable (lower ainity) suggesting hydrogen bonding and electro-
static interactions dominating the interaction. The variation of pH and temperature did not have a great impact
on the thermodynamics of the binding process, as observed from the similarity in enthalpy (ΔH), entropy (ΔS) or
Gibbs free energy (ΔG). A slight reduction in the binding ainity (Ka) with varing pH and temperature was
however observed. SEM/EDX studies showed the occurrence of changes in the microstructural properties of MAS
following complexation which may explain the potential of MAS-PPN complexes for controlled drug release
promoting pharmaceutical innovation.
1. Introduction
Sustained-release drug formulation is of high importance as it
achieves optimal therapeutic eicacy in chronic conditions where
treatment must be administered at constant levels over a period of time,
and provides a reduced frequency of side efects (Aulton, 2007). In
recent years, excipients such as clay minerals have often been used as
carriers of active ingredients to retard or modulate drug release
(Trikeriotis and Ghanotakis, 2007; Park et al., 2008; Joshi et al., 2009;
Meng et al., 2009; Pongjanyakul et al., 2009; Rojtanatanya and
Pongjanyakul, 2010). Their physicochemical properties make them
suitable to be used in the formulation of pharmaceutical dosage forms,
as they can adsorb the active ingredient onto their structure and form
complex dispersions and particles (Carretero and Pozo, 2009;
Pongjanyakul et al., 2009; Rojtanatanya and Pongjanyakul, 2010;
Kanjanakawinkul et al., 2013; Rongthong et al., 2013). These have been
shown to modify the release of drugs upon administration, which would
be desirable for drugs having a short half-life and require frequent
administration to maintain adequate drug plasma levels (Rojtanatanya
and Pongjanyakul, 2010).
Magnesium aluminium silicate (MAS) used in this research is a
mixture of natural smectite montmorillonite and saponite clays, often
used to improve the physical characteristics of drugs and to control
their release (Pongjanyakul et al., 2009; Kanjanakawinkul et al., 2013).
MAS has a high surface area, a very good ainity with cationic drugs
and it is neither toxic nor irritant, therefore being suitable to be used
within drug formulation. MAS has a layered silicate structure, formed of
one alumina or magnesia octahedral sheet, sandwiched between two
tetrahedral silicate sheets (Fig. 1) (Kanjanakawinkul et al., 2013). Hy-
dration in polar liquids easily allows the delamination of MAS platelets,
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which would otherwise be very di cult to achieve mechanically, due to
the binding efect of counter ions and water found between platelets.
Water easily forces the clay platelets further apart as it penetrates be-
tween them (osmosis) and hence cations difuse away from platelet
faces (difusion) (Vanderbilt Minerals, 2014a,b). This allows the ex-
posure of the negative face of the clay platelets which, in turn, allows
the adsorption of cationic drugs via electrostatic interactions (Nunes
et al., 2007; Pongjanyakul et al., 2009; Rojtanatanya and Pongjanyakul,
2010).
The present study investigates a potential clay-based formulation of
a model cationic drug propranolol hydrochloride (PPN) selected on the
basis of its important therapeutic efect but short half-life. PPN re-
presents the irst of drugs acting as antagonists at β-adrenergic re-
ceptors of the heart (β-blockers), developed in the 1960s and in-
troduced in 1964 (Patrick, 2001; Rojtanatanya and Pongjanyakul,
2010). Its therapeutic efect comes from antagonizing the adrenergic
pathway that can lead to blocking receptors in heart, lungs, liver,
pancreas, peripheral blood vessels and other parts of the body. It is used
to treat angina pectoris, myocardial infarction and high blood pressure.
However, due to its high solubility in water, PPN has a short half-life of
3.9 h and hence, it needs to be administered frequently (2–3 times/day)
in order to maintain adequate drug plasma levels (Datta, 2013). The
development of sustained-release dosage forms would be beneicial,
increasing patient compliance, safety and eicacy of the drug.
Here, the authors have studied the adsorption of PPN onto MAS
using isothermal titration calorimetry (ITC), high performance liquid
chromatography (HPLC), attenuated total relectance Fourier transform
infrared spectroscopy (ATR-FTIR) and scanning electron microscopy
with energy dispersive X-ray spectroscopy (SEM/EDX).
Isothermal titration calorimetry (ITC) is the only technique able to
completely characterise the thermodynamics of an interaction in a
single experiment (MicroCal, 1998). ITC is a powerful well-established
biophysical technique used to measure the formation and dissociation
of molecular complexes in many branches of science from cell biology
to food chemistry. ITC can be successfully used to study interactions
using a wide variety of samples such as clays, polymers, metals, pro-
teins, enzymes, hormones, antibodies and nanoparticles (Ladbury and
Chowdhry, 1996; Penn and Warren, 2009; Le et al., 2013). Traditional
ITC experiments with multiple discrete injections have previously been
used to provide accurate and important information about the me-
chanisms of binding of molecules (Callies and Hernández Daranas,
2016). Single injections experiments are faster and versatile, as the user
can generate the binding isotherm in one third to half the time a
multiple injection experiment takes, allowing the rapid determination
of the suitable conditions and parameters for the reaction, as well as the
driving forces to the reaction (Malvern Instruments, 2015). To perform
an experiment, the instrument periodically injects a ligand (guest so-
lution) into the calorimetric cell containing an analyte (host solution)
under isothermal conditions (Fig. 2) (Duf et al., 2011). The heat ab-
sorbed or released as chemical bonds form or break is then measured as
the power that must be supplied to maintain both sample and reference
cells at a constant temperature (Moore et al., 2016; Di Trani et al.,
2017). Experiments can be performed under diferent conditions, such
as variable temperatures or bufer giving detailed information about the
studied systems (Duf et al., 2011). Independent binding sites, se-
quential binding sites, competitive binding and dissociation models can
be itted to the resulting data to yield binding site size, ainity (Ka),
changes in enthalpy (ΔH), entropy (ΔS) or Gibbs free energy (ΔG) and
stoichiometry (N) of the binding events (Moore et al., 2016). For a
simple single binding site model, the non-linear least squares it of the
data can be used to determine Ka and ΔH, followed by the calculation of
ΔG and ΔS using the known relationship between the van’t Hof
equation and change in Gibbs free energy:
=
=
G H T S
RTlnK
(1a)
(1b)a
where T is the absolute temperature in Kelvin and R is the gas
constant.
The change in heat capacity of the binding interaction at constant
pressure (ΔCp) may also be determined by undertaking experiments at
additional temperatures. ΔCp is determined from the temperature de-
pendence of ΔH using Eq. (2) (MicroCal, 1998; Le et al., 2013):
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In certain cases, more complex models (with equilibria involving
multiple binding mechanisms) are used to predict the thermodynamics
Fig. 1. Alumina or magnesia sheet composed of octahedron structures joined
together and sandwiched between two silica sheets composed of silica tetra-
hedron structures joined together (adapted from (Vanderbilt Minerals, 2014b)).
Fig. 2. Schematic diagram of an ITC micro calorimeter.
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of the binding event (Le et al., 2013; Callies and Hernández Daranas,
2016). A spontaneous interaction will have a negative ΔG and, as the
binding increases in strength, ΔG will also become increasingly nega-
tive. ΔG for a binding isotherm has both an entropic and an enthalpic
contribution.
The present study aimed at exploiting ITC in giving insights to the
binding that occurs in clays and model cationic drugs through the ob-
servation of the process in real time and determination of the driving
forces that could potentially afect drug release. The real-time process
of adsorption of cationic drugs onto clay minerals has not been de-
scribed prior to this study and as such understanding it is a critical step
in establishing a successful formulation thus promoting pharmaceutical
innovation.
2. Experimental
2.1. Materials
VEEGUM F EP (Magnesium Aluminium Silicate) was a gift from
R.T.Vanderbilt Company, Norwalk, CT (USA). Its composition was
conirmed by infrared (IR) spectroscopy and using a calcimeter. The
calcimeter used works in accordance to the method of Scheibler which
determines the carbonate content using a volumetric method
(Calcimeter Manual, 2018). The method involves the addition of hy-
drochloric acid to the clay sample which leads to the conversion of the
carbonates into CO2. The amount of CO2 released produces a diference
in pressure which is measured on a burette illed with water and dea-
erated. The diference in level on the burette is used to calculate the
carbonate content as an equivalent calcium carbonate content. This
material therefore complies with the European Pharmacopoeia mono-
graph for Magnesium Aluminium Silicate and is indicated for use as a
dry excipient in pressed powders and in direct compression tablets
(Vanderbilt Minerals, 2014a). Propranolol hydrochloride was supplied
from TCI (Tokyo Chemical Industry, Tokyo). Acetonitrile (HPLC grade),
sodium phosphate dibasic dihydrate, 99+% (HPLC grade), 2M sodium
hydroxide and 2M hydrochloric acid were purchased from Fisher Sci-
entiic (UK).
2.2. Methods
2.2.1. Formulation of MAS-PPN complex particles
MAS dispersions (2% w/v) and PPN solutions (2% w/v) were se-
parately prepared under continuous stirring at 500 rpm (25 °C) for 24 h
and 30min respectively. The pH of MAS dispersions and PPN solutions
prepared was further adjusted to pH 5 using 2M hydrochloric acid and
2M sodium hydroxide. For single drug loading, one PPN solution was
combined with one of the MAS dispersions prepared, and the obtained
dispersion (1:1 w/w) was incubated at 37 °C with shaking at 200 rpm
for 24 h (GLS Aqua 18 Plus, Linear Shaking Water Bath, Grant
Instruments). The MAS–PPN complex dispersion formed was then il-
tered using a Buchner iltration apparatus with vacuum. For the second
drug loading, previously iltered single drug loaded complexes prepared
was redispersed into a fresh drug solution (at pH 5) and incubated at
37 °C with shaking at 200 rpm for 24 h. The single and double loaded
MAS–PPN complex dispersions obtained were then iltered and dried in
the oven at 50 °C for 48 h. The complexed particles obtained were
ground using a Retsch PM 100 Ball Mill set at 350 rpm. The ground
samples were sieved to a particle size fraction of 123–65 µm and stored
in a glass vial until needed.
2.2.2. Characterisation of MAS-PPN complexes
2.2.2.1. Attenuated total reflectance Fourier transform infrared
spectroscopy (ATR-FTIR). ATR-FTIR was used to elucidate the
molecular interaction between MAS and PPN. Experiments were
performed on a Smart Orbit ATR-FTIR machine, using diamond as the
ATR crystal. MAS, PPN and MAS-PPN complexes (dried single and
double drug loaded complexes) were scanned from 4000 to 400 cm−1.
2.2.2.2. Scanning electron microscopy with energy dispersive X-ray
spectroscopy (SEM/EDX). The surface morphology in 3D and the
energy spectrum of samples was analysed using a QUANTA FEG 250
microscope equipped with an EDX to detect changes that occurred
following the complexation process. The electronic beam voltage of the
microscope was set at 20 kV. A small amount of either PPN, MAS or the
single and double loaded MAS-PPN complexed samples was mounted
on a metal stub with double-sided adhesive tape and sputter coated
with a thin layer of gold (1–5 nm) under vacuum (argon atmosphere).
Various magniications were taken of the micrographs to aid in the
study of the complexes.
2.2.3. Drug content analysis from single and double loaded MAS-PPN
complexes
Drug content within the single and double loaded MAS-PPN com-
plexes was determined by dispersing 50mg of the prepared single or
double drug loaded MAS-PPN complex particles in 100mL of a 2M HCl,
ultra–pure water or pH 6.8 phosphate bufer under continuous stirring
for 24 h, at 25 °C and 700 rpm. The suspensions obtained were then
iltered using 0.2 µm syringe ilters. The clear supernatant was analysed
using HPLC (Section 2.2.4) to determine drug content in the MAS–PPN
complexes. The experiments were performed in triplicate to ensure
reproducibility.
2.2.4. High performance liquid chromatography (HPLC)
Reversed phase high performance liquid chromatography was per-
formed using a Shimadzu HPLC system (Shimadzu, Japan), equipped
with an SPD-20AV UV–Vis detector, using an XTerra MS C18
150mm×4.6mm×3.5 μm column. The mobile phase was prepared
using acetonitrile and 0.01M sodium phosphate dibasic dihydrate (pH
3.5) at a ratio of 30:70 v/v. The low rate of the mobile phase was set at
1mL/min with a detection wavelength of 230 nm.
2.2.4.1. Method validation. The HPLC method used was validated by
the following parameters: linearity range, precision, limit of
quantitation (LOQ) and limit of detection (LOD) (Modamio et al.,
1996). Linearity was evaluated over a series of drug stock solutions
ranging from 100 to 0.1 µg/mL, prepared with appropriate volumes. A
calibration graph was then generated by plotting the peak area versus
the corresponding drug concentration (R2≥0.999). The results were
recorded in triplicate on three diferent days. The intra and inter day
precision was determined from an assay of freshly prepared 1, 10, 50
and 100 µg/mL standard drug solutions, repeatedly run on the same day
or on three diferent days. Results were evaluated statistically in terms
of standard deviation (RSD %) (Ich, 2005). The intermediate and intra
assay precision at three diferent concentration levels was lower than
2% RSD which complied with the acceptable criteria for quality control
of pharmaceutical preparations (Ermer and Ploss, 2005; Chatpalliwar
et al., 2012).
As a consequence of the basic nature of PPN, its analysis using HPLC
was prone to peak tailing and poor peak shape from column over-
loading (McCalley, 2010; Sadeghi et al., 2013). Therefore, the sensi-
tivity of the method is important in ensuring a good peak resolution and
eiciency to avoid sample overloading (Sadeghi et al., 2013). The LOQ
conirming the lowest drug concentration that can be recovered within
acceptable limits of precision and accuracy was found to be 2.30 µg/
mL, indicating the high sensitivity of the proposed method and its
suitability for the detection of PPN in solution at low concentrations
(Table 1). Furthermore, the LOD was determined to be 0.76 µg/mL
which also highlighted the sensitivity of the method.
2.2.5. Calorimetric binding studies
The VP-ITC instrument was calibrated to ensure its robustness,
speed and ease of evaluation and to ensure the instrument was within
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acceptable limits (Fig. 3) (Baranauskiene et al., 2009). Calorimetric
binding studies were undertaken using a VP-ITC micro calorimeter
(Malvern Panalytical, UK) with the MAS dispersion in the sample cell
and the PPN solution in the syringe. The instrument was used in high-
gain feedback mode, applying a reference power of 20 μcal s−1 whilst
stirring 307 rpm. The acidity of the working media (pH 5, 7, 9) in this
study was chosen based on the pKa value of PPN (9. 5) (Shalaeva et al.,
2007; Rojtanatanya and Pongjanyakul, 2010; ACD I-Lab, 2018). At
these pHs, PPN is expected to be adsorbed onto the negatively charged
MAS as it is ionised. 2M hydrochloric acid and 2M sodium hydroxide
were used in adjusting the pH (ACD I-Lab, 2018). The results were
analysed using Origin 7.0 (Microcal, Inc) software. Experiments were
repeated in triplicate to ensure reproducibility.
Calorimetric single injection mode (SIM) binding studies were car-
ried out at 25 °C and three diferent pH values, 5, 7 and 9 to char-
acterise the process of adsorbing PPN onto MAS and to identify the most
suitable conditions and parameters for the reaction. The drug solution
was added as one 150 µL injection into the sample cell. MAS dispersions
(0.037% w/v) and PPN solutions (0.150% w/v) were prepared using
puriied water under continuous stirring at 500 rpm (25 °C) for 24 h and
30min respectively prior to analysis. The pH of the prepared solutions
and dispersions was further adjusted to 5, 7 and 9. The binding iso-
therm was analysed by comparing the reaction rate for the adsorption
of PPN onto MAS at the pH values studied. Furthermore, the evolved
heat in the experiments was analysed through a single set of sites curve
itting using a non-linear least squares model. This allowed the de-
termination of the association constant Ka and the thermodynamic
parameters ΔH, ΔG and ΔS.
Calorimetric multiple injection mode (MIM) binding studies were
carried out at pH 5 and at two diferent temperatures (25 °C and 37 °C).
The real-time binding isotherm was studied with 120 injections of 2 μL
each into the sample cell every 260 s. MAS dispersion (0.037% w/v)
and PPN solutions (0.150% w/v) were prepared as detailed previously.
3. Results and discussion
3.1. Chemical overview of MAS
The constituents of the MAS were conirmed to be a mixture of clay
minerals and carbonates (Table 2). The high percentage of magnesia
and alumina conirms the presence of both montmorillonite and sapo-
nite clays within the material (Table 2) (Kanjanakawinkul et al., 2013).
Low quantities of ferric oxide, calcium oxide, potassium oxide and so-
dium oxide, as well as trace amounts of titanium oxide were observed,
conirming the presence of exchangeable cations adsorbed onto the clay
structure via electrostatic interactions. A loss on ignition of 11.90%
resulted from the loss of water, organic matter and carbonates upon
heating the sample between 120 and 150 °C (Weems, 1903). The MAS
sample was further analysed by heating it to 900–1100 °C. This process
produced 3.06% CO2 which was a result of the thermal decomposition
of the carbonates.
3.2. Solid state characterisation
3.2.1. Attenuated total reflectance Fourier transform infrared spectroscopy
(ATR-FTIR)
ATR-FTIR was used to study the adsorption onto MAS of PPN based
on the vibration of chemical bonds formed (Fig. 4). The spectrum of
MAS alone indicated the presence of the hydroxyl group belonging to
SiOH at 3625 cm−1 and SiOSi stretching at 980 cm−1
(Rojtanatanya and Pongjanyakul, 2010). Also, a broad peak at
3415 cm−1 (OH stretching of water residues) and a sharp peak at
1640 cm−1 (hydroxyl group bending of water of crystallization) were
observed (Rojtanatanya and Pongjanyakul, 2010). The spectrum of PPN
Table 1
HPLC method validation for PPN.
Range (µg/mL) Linearity (R2) Intermediate precision (RSD) (%) Intra assay precision (RSD) (%) LOD (µg/mL) LOQ (µg/mL)
PPN 100–0.1 ≥0.9998 1 µg/mL: 5.60
10 µg/mL: 1.04
50 µg/mL: 0.25
100 µg/mL: 0.33
1 µg/mL: 1.62
10 µg/mL: 0.55
50 µg/mL: 0.09
100 µg/mL: 0.61
0.76 2.30
Fig. 3. Titration of 1Mm CaCl2 into 0.1Mm EDTA solution at pH 6 (25 °C). Raw
data (top) and integrated heats (bottom) as a function of molar ratio.
Table 2
Chemical analysis of VEEGUM F EP/ MAS conirming the amount of oxides
and carbonates present in the sample as weight (%). Results obtained using IR
spectroscopy and Calcimeter.
Weight (%) Weight (%)
Silica 58.63 Calcium carbonate 1.13
Ferric oxide 2.50 Magnesium carbonate 2.55
Alumina 11.91 Sodium carbonate 0.71
Calcium oxide 2.43 Potassium carbonate 2.55
Magnesia 7.69 Total 6.94
Sodium oxide 1.44
Potassium oxide 3.26
Titanium oxide 0.09
Loss on ignition 11.90
Total 99.85
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Fig. 4. ATR-FTIR spectra of PPN, MAS and single and double drug loaded MAS-PPN complex particles.
Fig. 5. Surface characterisation of MAS using SEM/EDX. SEM images at diferent magniications ×500 (a), ×1500 (b), ×5000 (c) and ×10,000 (d); atomic
distribution proile at ive diferent sample locations (Spectrum 1–5).
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alone displayed three distinctive peaks occurring between 3380 and
3185 cm−1 which can be attributed to the secondary hydroxyl and
amine groups within its structure. The peak observed at 1268 cm−1 was
attributed to aryl alkyl ether stretching, whilst the peak at 970 cm−1
was attributed to the naphthalene group within PPN (Rojtanatanya and
Pongjanyakul, 2010; Saeedi et al., 2013). Analysis of the single and
double drug loaded MAS – PPN complexes displayed spectrums very
diferent from the spectrum of PPN or MAS alone. The presence of the
Si-O-Si stretching at 980 cm−1 from the clay was still observed, whereas
the peak for the hydroxyl stretching of SiOH became smaller and
Fig. 6. Characterisation of PPN surface using SEM/EDX. SEM images at diferent magniications ×500 (a), ×1500 (b), ×5000 (c) and ×10,000 (d); atomic
distribution proile at two diferent sample locations (Spectrum 1 and 2).
Fig. 7. Surface characterisation of MAS-PPN single drug loaded complex using SEM/EDX. SEM images at diferent magniications ×500 (a), ×1500 (b), ×5000 (c)
and ×10,000 (d); atomic distribution proile at ive diferent sample locations (Spectrum 1–5).
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shifted to a lower wavelength at approximately 3631 cm−1. Peaks at-
tributed to the secondary hydroxyl and amine groups within PPN were
no longer visible. Hence, the change and disappearance of peaks from
both MAS and PPN conirmed PPN adsorption onto MAS, via hydrogen
bond formation between the silanol groups of MAS with the amine and/
or hydroxyl groups of PPN (Rojtanatanya and Pongjanyakul, 2010).
3.2.2. Scanning electron microscopy with energy dispersive X-ray
spectroscopy (SEM/EDX)
SEM images of the MAS particles were shown to be aggregated to-
gether in comparatively large clusters (Fig. 5) (Mita, Rupa and
Achowicz, 2010; Pongjanyakul and Rojtanatanya, 2012). Individual
lakes were also observed on the surface upon increasing magniication
which represents the tetrahedral and octahedral sheets which are
characteristic of phyllosilicates (Carrado and Bergaya, 2007). The
atomic distribution onto the MAS surface using EDX revealed the
presence of high amounts of silicon, aluminium and magnesium, as well
as trace amounts of iron, calcium, sodium, titanium and potassium
(Fig. 5). The high percentage of silicon, magnesium and aluminium
conirmed the presence of both montmorillonite and saponite clays
within the material, whereas the other elements may indicate its pro-
venience (Kanjanakawinkul et al., 2013). The results were thus in
agreement with that produced by the IR and calcimeter (Table 2). PPN
was shown to be formed of large crystalline particles having smooth
surfaces (Fig. 6). EDX analysis of PPN conirmed the presence of dis-
tinctive elements such as chlorine and nitrogen.
The analysis of the single and double drug loaded MAS-PPN com-
plex particles using SEM/EDX (Figs. 7 & 8) indicated that both samples
were similar, yet diferent when compared with MAS and PPN alone.
These results indicate that changes in the microstructural properties of
the clay powder occurred following the complexation process which
may explain why the formed MAS-PPN complexes can be used to ofer
controlled drug release (Rojtanatanya and Pongjanyakul, 2010;
Pongjanyakul and Rojtanatanya, 2012). The analysis of atomic dis-
tribution in the single and double drug loaded MAS-PPN complex
particles revealed the presence of elements belonging to both PPN and
MAS which was expected.
3.3. Recovery of PPN content from MAS–PPN complex particles
Drug recovery from the single and double drug loaded MAS–PPN
complex particles was inluenced by the dissolution media used
(Table 3). A higher amount of PPN was recovered from the complexes
in 2M HCl and pH 6.8 bufer compared with ultra-pure water sug-
gesting that the polydispersity of MAS particles was inluenced by the
Fig. 8. Surface characterisation of MAS-PPN double drug loaded complex using SEM/EDX. SEM images at diferent magniications ×500 (a), ×1500 (b), ×5000 (c)
and ×10,000 (d); atomic distribution proile at ive diferent sample locations (Spectrum 1–5).
Table 3
PPN content in single drug loaded and double drug loaded MAS–PPN complex
particles using three diferent dissolution media (2M HCl, ultra-pure water (pH
5) and phosphate bufer (pH 6.8)).
Recovered PPN (% w/w)
MAS-PPN single drug
loaded
MAS-PPN double drug
loaded
2M HCl 19.53 ± 0.01* 25.94 ± 0.42*
pH 5.0 Ultra-pure water 9.54 ± 0.14* 16.09 ± 0.57*
pH 6.8 Phosphate Bufer 12.61 ± 0.18* 20.65 ± 0.55*
Note: *values are reported as the mean ± SD of at least three determinations.
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Fig. 9. SIM titration of PPN solution (0.150% w/v) into MAS dispersion (0.037% w/v) at pH 5 (black), pH 7 (red) and pH 9 (blue) (25 °C). The return to the baseline
highlighted in purple is used to determine the most favourable (higher ainity) dissolution media for the interaction (n=3) (a), data analysed through one set of
sites curve itting showing the enthalpy change (kcal mol−1 of injectant) at pH 5 (b), pH 7 (c) and pH 9 (d) all at 25 °C (n=3). (For interpretation of the references to
colour in this igure legend, the reader is referred to the web version of this article.)
Table 4
Calculated thermodynamic parameters using SIM calorimetric data regarding the adsorption of PPN (0.150% w/v) onto MAS (0.037% w/v) at pH 5, 7 and
pH 9 (25 °C) (n=3).
pH 5 pH 7 pH 9
Ka 2.22E+04 ± 0.00 1.67E+04 ± 1.91E+03 1.07E+04 ± 2.52E+03
ΔG
kcal/mol −5.46 ± 0.19 −5.48 ± 0.05 −5.87 ± 0.12
kJ/mol − 22.84 ± 0.79 −22.92 ± 0.21 −24.56 ± 0.50
ΔH
kcal/mol −7.62 ± 0.96 −7.33 ± 0.38 −8.20 ± 0.56
kJ/mol −31.88 ± 4.02 −30.66 ± 1.59 −34.30 ± 2.34
−TΔ S
kcal/mol/K 2.16 ± 0.71 1.85 ± 0.96 2.33 ± 1.76
kJ/mol/K 9.04 ± 2.97 7.74 ± 4.02 9.75 ± 7.36
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cations present in the dissolution media (Rojtanatanya and
Pongjanyakul, 2010). An increase in the PPN content was also observed
in the MAS–PPN double drug loaded complexes suggesting that there
were still available binding sites onto MAS after adsorption equilibrium
was reached following the single drug loading which allowed further
adsorption of PPN particles (Rojtanatanya and Pongjanyakul, 2010). It
is key to note that no impurities or degradants were observed. This
information is of high importance as it can afect the accurate
quantiication of PPN from MAS–PPN complexes which, in turn, can
impact on the formulation of a tablet dosage form.
3.4. Calorimetric binding studies
3.4.1. Single injection mode (SIM)
SIM experiments conirmed the adsorption of PPN onto MAS at the
three pH values studied (pH 5, 7 and 9). This process was highly
Fig. 10. An example of a multiple injection mode calorimetric titration of PPN solution (0.150% w/v, pH 5) into MAS dispersion (0.037% w/v, pH 5) at 25 °C. Raw
data (top) and integrated heats (bottom) as a function of molar ratio (a), thermodynamic proile for binding of PPN onto MAS at 25 °C (b), multiple injection mode
calorimetric titration of PPN solution (0.150% w/v, pH 5) into MAS dispersion (0.037% w/v, pH 5) at 37 °C. Raw data (top) and integrated heats (bottom) as a
function of molar ratio (c) and thermodynamic proile for binding of PPN onto MAS at 37 °C (d).
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exothermic and became more energetic as pH decreased, indicated by
the peak returning more rapidly to the baseline (Fig. 9a). This can be
attributed to the ionisation of the drug (pka 9. 5) (Shalaeva et al., 2007;
Rojtanatanya and Pongjanyakul, 2010; ACD I-Lab, 2018). It is im-
portant to note also that the MAS polydispersity may be afected by the
ions in the solution which, in turn can afect the rate of adsorption of
PPN onto MAS (Rojtanatanya and Pongjanyakul, 2010). SIM experi-
ments through a single set of sites curve itting using a non-linear least
squares model allowed the observation of behaviour of adsorption of
PPN onto MAS with varying pH (Fig. 9b–d and Table 4). In all cases, the
overall change in enthalpy was found to be exothermic with a com-
paratively small entropic contribution to the total change in Gibbs free
energy. These indings irstly imply that the binding phenomenon was
predominantly enthalpically driven as high energy resulted from
broken and created hydrogen bonds and electrostatic interactions.
Secondly the similarity in values implies that pH did not afect the
thermodynamics of the binding process. The binding ainity (Ka)
slightly decreased with varing pH (Table 4) suggesting that at pH 5 the
adsorption process was more energetic and the conditions for the re-
action were optimum. The ITC data is thus in agreement with previous
results published in literature showing that the adsorption of PPN onto
MAS is enthalpically driven and entropically unfavourable suggesting
hydrogen bonding and electrostatic interactions dominate the interac-
tion (Rojtanatanya and Pongjanyakul, 2010; Pongjanyakul and
Rojtanatanya, 2012).
3.4.2. Multiple injection mode
Multiple injection experiments at pH 5 and at two diferent tem-
peratures (25 and 37 °C) further conirmed the highly exothermic in-
teraction between PPN and MAS (Fig. 10), as observed in the SIM ITC
experiments. The MIM stepwise experiments however gave detailed and
more accurate information about the driving forces involved in the
adsorption process compared with the SIM experiments. In agreement
with previous SIM experiments, binding was characterised by a nega-
tive enthalpy change, and a comparatively small entropy change, i.e.
implying that it was an enthalpically driven process (Fig. 10). The ad-
sorption process of PPN onto MAS was shown to be similar at both 25
and 37 °C (Fig. 10b and d). The increase in temperature slightly de-
creased the ainity of PPN with MAS as observed from the reduction of
the association constant Ka (2.61E+04 ± 2.71E+03M at 25 °C and
1.48E+04 ± 1.48E+03M at 37 °C). The overall change in Gibbs free
energy (ΔG) was comparatively similar at both temperatures
(−6.03 ± 0.06 kcal/mol (−25.23 ± 0.25 kJ/mol) at 25 °C compared
with −5.97 ± 1.37 kcal/mol (−24.98 ± 5.73 kJ) at 37 °C), con-
irming both reactions occurred spontaneously. The enthalpic con-
tribution calculated from the change in heat associated with binding
was greater at 37 °C (−11.37 ± 1.36 kcal/mol (47.57 ± 5.69 kJ)
compared with −8.54 ± 0.32 kcal/mol (−35.73 ± 1.34 kJ) at 25 °C),
while the entropic contribution was comparatively small in both cases
conirming the interaction to be enthalpically driven at both tempera-
tures. The binding interaction had a negative heat capacity ΔCp
(−0.24 kcal mol K−1/ −1.00 kJmol K−1) indicating that upon in-
creasing temperature the binding became more exothermic and en-
thalpically driven, thus in agreement with the binding parameters
calculated.
4. Conclusion
This study demonstrated the ainity of PPN for MAS and provided
insights into its binding energetics. The process was shown to be exo-
thermic, enthalpically driven and entropically unfavourable (lower af-
inity) suggesting hydrogen bonding and electrostatic interactions
dominating the interaction. A simple, accurate and precise reversed-
phase HPLC method was developed for quantitative determination of
PPN from the single and double drug loaded MAS–PPN complex par-
ticles which showed that PPN recovery was inluenced by the
dissolution media used, information which can impact on the for-
mulation of a tablet dosage form. Changes in the microstructural
properties of the clay powder following the complexation process were
also observed which may explain why the formed MAS-PPN complexes
could be used to ofer controlled drug release strategies. ATR-FTIR
conirmed PPN adsorption onto MAS, via hydrogen bond formation
between the silanol groups of MAS with the amine and/or hydroxyl
groups of PPN based on the vibration of chemical bonds formed. The
detailed information presented in this study on the binding energetics
and behaviour between PPN and MAS is of great importance to a for-
mulator in the development of complexes for the manipulation of drug
release.
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